Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
WS02 - IASLC CT Screening Symposium: Forefront Advances in Lung Cancer Screening (Ticketed Session) (In-person Access Only)
- 09:00 - 16:00
- 8/05/2022
- Location: Strauss 3
- Not for CME Credit
- Type: Workshop
- Track: N/A
- Moderators:Chunxue Bai, David Baldwin, Ella A Kazerooni, Stephen Lam, Annette Maree McWilliams, Harry J de Koning
-
+
WS02.09 - Key Elements for Successful Implementation of a National Screening Program - The Taiwan Experience
09:15 - 09:25 | Presenter: Pan Chyr Yang
- Abstract
Loading...
-
+
ES04 - Current Status of Lung Cancer Screening Worldwide
- 12:00 - 13:00
- 8/07/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Education Session
- Track: Early Detection and Screening
- Moderators:Torsten Gerriet Blum, Ricardo Sales Santos, Mónica Castro
-
+
ES04.05 - Lung Cancer Screening in Asia for Individuals Without a Smoking History
12:15 - 12:27 | Presenter: Pan Chyr Yang
- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-028 - Overestimation with Cox HR - Cox-TEL-Adjusted Associations of PD-L1 Expression with Immune Checkpoint Inhibitor Survival Benefit in Lung Cancer
Presenter: Emily Pei-Ying Lin- Abstract
Loading...
